Patents by Inventor Paul Rohricht

Paul Rohricht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
    Patent number: 10912863
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: February 9, 2021
    Assignee: Revivicor, Inc.
    Inventors: David Ayares, Paul Rohricht
  • Tissue Products Derived from Animals Lacking any Expression of Functional Alpha 1, 3 Galactosyltransferase
    Publication number: 20190111180
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Application
    Filed: October 24, 2018
    Publication date: April 18, 2019
    Inventors: David Ayares, Paul Rohricht
  • Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
    Patent number: 10130737
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: November 20, 2018
    Assignee: Revivicor, Inc.
    Inventors: David Ayares, Paul Rohricht
  • Tissue Products Derived from Animals Lacking any Expression of Functional Alpha 1, 3 Galactosyltransferase
    Publication number: 20150182664
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Application
    Filed: August 1, 2014
    Publication date: July 2, 2015
    Applicant: Revivicor, Inc.
    Inventors: David Ayares, Paul Rohricht
  • Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
    Publication number: 20120282226
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Application
    Filed: December 22, 2011
    Publication date: November 8, 2012
    Inventors: David Ayares, Paul Rohricht
  • Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
    Patent number: 8106251
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: January 31, 2012
    Assignee: Revivicor, Inc.
    Inventors: David Ayares, Paul Rohricht
  • Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
    Publication number: 20050260176
    Abstract: The present invention provides tissues derived from animals, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha-1,3-GT). Such tissues can be used in the field of xenotransplantation, such as orthopedic reconstruction and repair, skin repair and internal tissue repair or as medical devices.
    Type: Application
    Filed: March 17, 2005
    Publication date: November 24, 2005
    Applicant: Revivicor, Inc.
    Inventors: David Ayares, Paul Rohricht